[Usefulness of ARB in heart failure].

Research output: Contribution to journalReview article

Abstract

An angiotensin receptor blocker (ARB) is recommended as an alternative in patients with heart failure and left ventricular ejection fraction less than 40% intolerant of an ACE inhibitor. In these patients, an ARB reduces the risk of death from a cardiovascularcause or hospital admission for worsening heart failure. It is also recommended in patients with heart failure who remain symptomatic despite optimal treatment with an ACE inhibitor and beta-blocker. Treatment with an ARB improves ventricular function and patient well-being, and reduces hospital admission for worsening heart failure. In patients with heart failure and preserved left ventricular ejection fraction, although no treatment has yet been shown, convincingly, to reduce morbidity and mortality, adequate treatment of hypertension is important and ARB is considered to be able t o reduce the risk of admissionsfor heart failure.

Original languageEnglish
Pages (from-to)751-757
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume67
Issue number4
Publication statusPublished - Jan 1 2009
Externally publishedYes

Fingerprint

Angiotensin Receptor Antagonists
Heart Failure
Angiotensin-Converting Enzyme Inhibitors
Stroke Volume
Ventricular Function
Therapeutics
Hypertension
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[Usefulness of ARB in heart failure]. / Tsutsui, Hiroyuki.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 67, No. 4, 01.01.2009, p. 751-757.

Research output: Contribution to journalReview article

@article{c1bdcf39b07f4318bef11b4c1ad23eb0,
title = "[Usefulness of ARB in heart failure].",
abstract = "An angiotensin receptor blocker (ARB) is recommended as an alternative in patients with heart failure and left ventricular ejection fraction less than 40{\%} intolerant of an ACE inhibitor. In these patients, an ARB reduces the risk of death from a cardiovascularcause or hospital admission for worsening heart failure. It is also recommended in patients with heart failure who remain symptomatic despite optimal treatment with an ACE inhibitor and beta-blocker. Treatment with an ARB improves ventricular function and patient well-being, and reduces hospital admission for worsening heart failure. In patients with heart failure and preserved left ventricular ejection fraction, although no treatment has yet been shown, convincingly, to reduce morbidity and mortality, adequate treatment of hypertension is important and ARB is considered to be able t o reduce the risk of admissionsfor heart failure.",
author = "Hiroyuki Tsutsui",
year = "2009",
month = "1",
day = "1",
language = "English",
volume = "67",
pages = "751--757",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "4",

}

TY - JOUR

T1 - [Usefulness of ARB in heart failure].

AU - Tsutsui, Hiroyuki

PY - 2009/1/1

Y1 - 2009/1/1

N2 - An angiotensin receptor blocker (ARB) is recommended as an alternative in patients with heart failure and left ventricular ejection fraction less than 40% intolerant of an ACE inhibitor. In these patients, an ARB reduces the risk of death from a cardiovascularcause or hospital admission for worsening heart failure. It is also recommended in patients with heart failure who remain symptomatic despite optimal treatment with an ACE inhibitor and beta-blocker. Treatment with an ARB improves ventricular function and patient well-being, and reduces hospital admission for worsening heart failure. In patients with heart failure and preserved left ventricular ejection fraction, although no treatment has yet been shown, convincingly, to reduce morbidity and mortality, adequate treatment of hypertension is important and ARB is considered to be able t o reduce the risk of admissionsfor heart failure.

AB - An angiotensin receptor blocker (ARB) is recommended as an alternative in patients with heart failure and left ventricular ejection fraction less than 40% intolerant of an ACE inhibitor. In these patients, an ARB reduces the risk of death from a cardiovascularcause or hospital admission for worsening heart failure. It is also recommended in patients with heart failure who remain symptomatic despite optimal treatment with an ACE inhibitor and beta-blocker. Treatment with an ARB improves ventricular function and patient well-being, and reduces hospital admission for worsening heart failure. In patients with heart failure and preserved left ventricular ejection fraction, although no treatment has yet been shown, convincingly, to reduce morbidity and mortality, adequate treatment of hypertension is important and ARB is considered to be able t o reduce the risk of admissionsfor heart failure.

UR - http://www.scopus.com/inward/record.url?scp=79959342719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959342719&partnerID=8YFLogxK

M3 - Review article

C2 - 19348238

AN - SCOPUS:79959342719

VL - 67

SP - 751

EP - 757

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 4

ER -